Enhertu Boosts PFS in Pretreated, HR-Positive, HER2-Low and -Ultralow Breast Cancer
Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.
Stay updated with breaking news from Clinical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.
Researchers analyzed multi-omic data from 231 people with PTSD or depression to uncover distinct molecular differences that might affect systems such as the nervous and immune systems, to contribute to these mental health conditions.
A comprehensive approach that examines the intersection of multiple biological processes is necessary to elucidate the development of stress-related disorders. In a new study, investigators from McLean Hospital, a member of the Mass General Brigham health care system, working with colleagues at The University of Texas at Austin and Lieber Institute for Brain Development, uncovered both shared and distinct molecular changes across brain regions, genomic layers, cell types, and blood in individuals with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD).
The podcast by pharmacists, for pharmacists, brought to you by the AJP. Each episode, join a diverse panel of pharmacists from all settings and experience levels discussing topics that affect pharmacists in day to day practice.
Patrick Ott, MD, PhD, discusses the investigation of cancer vaccines, highlighting the clinical implications of this treatment modality in melanoma.